These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 30092355)
21. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer. Miao Y; Fan R; Chen L; Qian H Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303 [TBL] [Abstract][Full Text] [Related]
22. Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer. Zhang HD; Jiang LH; Hou JC; Zhong SL; Zhou SY; Zhu LP; Li J; Wang DD; Sun DW; Ji ZL; Tang JH Biomed Pharmacother; 2018 Nov; 107():1342-1353. PubMed ID: 30257349 [TBL] [Abstract][Full Text] [Related]
23. Upregulation of long non-coding RNA XIST has anticancer effects on epithelial ovarian cancer cells through inverse downregulation of hsa-miR-214-3p. Wang C; Qi S; Xie C; Li C; Wang P; Liu D J Gynecol Oncol; 2018 Nov; 29(6):e99. PubMed ID: 30207107 [TBL] [Abstract][Full Text] [Related]
24. ADAMTS6 suppresses tumor progression via the ERK signaling pathway and serves as a prognostic marker in human breast cancer. Xie Y; Gou Q; Xie K; Wang Z; Wang Y; Zheng H Oncotarget; 2016 Sep; 7(38):61273-61283. PubMed ID: 27542224 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST. Zhuang LK; Yang YT; Ma X; Han B; Wang ZS; Zhao QY; Wu LQ; Qu ZQ Cell Death Dis; 2016 Apr; 7(4):e2203. PubMed ID: 27100897 [TBL] [Abstract][Full Text] [Related]
26. Circulating LncRNAs landscape as potential biomarkers in breast cancer. Pourramezan Z; Attar FA; Yusefpour M; Azizi M; Oloomi M Cancer Rep (Hoboken); 2023 Feb; 6(2):e1722. PubMed ID: 36274054 [TBL] [Abstract][Full Text] [Related]
27. XIST promotes gastric cancer (GC) progression through TGF-β1 via targeting miR-185. Zhang Q; Chen B; Liu P; Yang J J Cell Biochem; 2018 Mar; 119(3):2787-2796. PubMed ID: 29053187 [TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer. Zuo Y; Li Y; Zhou Z; Ma M; Fu K Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533 [TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression. Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846 [TBL] [Abstract][Full Text] [Related]
30. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer. Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144 [TBL] [Abstract][Full Text] [Related]
31. LncRNA XIST promotes extracellular matrix synthesis, proliferation and migration by targeting miR-29b-3p/COL1A1 in human skin fibroblasts after thermal injury. Cao W; Feng Y Biol Res; 2019 Sep; 52(1):52. PubMed ID: 31540582 [TBL] [Abstract][Full Text] [Related]
32. Selective expression of long non-coding RNAs in a breast cancer cell progression model. Tracy KM; Tye CE; Page NA; Fritz AJ; Stein JL; Lian JB; Stein GS J Cell Physiol; 2018 Feb; 233(2):1291-1299. PubMed ID: 28488769 [TBL] [Abstract][Full Text] [Related]
33. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling. Tang Y; Xiao G; Chen Y; Deng Y Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma. Chu YH; Hardin H; Schneider DF; Chen H; Lloyd RV Exp Mol Pathol; 2017 Oct; 103(2):229-236. PubMed ID: 29107050 [TBL] [Abstract][Full Text] [Related]
35. Establishment of twist-1 and TGFBR2 as direct targets of microRNA-20a in mesenchymal to epithelial transition of breast cancer cell-line MDA-MB-231. De S; Das S; Mukherjee S; Das S; Sengupta Bandyopadhyay S Exp Cell Res; 2017 Dec; 361(1):85-92. PubMed ID: 28987542 [TBL] [Abstract][Full Text] [Related]
36. LncRNA MT1JP Suppresses Gastric Cancer Cell Proliferation and Migration Through MT1JP/MiR-214-3p/RUNX3 Axis. Xu Y; Zhang G; Zou C; Zhang H; Gong Z; Wang W; Ma G; Jiang P; Zhang W Cell Physiol Biochem; 2018; 46(6):2445-2459. PubMed ID: 29742512 [TBL] [Abstract][Full Text] [Related]
37. Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development. Jin C; Yan B; Lu Q; Lin Y; Ma L Tumour Biol; 2016 Jun; 37(6):7383-94. PubMed ID: 26676637 [TBL] [Abstract][Full Text] [Related]
38. CsA Promotes XIST Expression to Regulate Human Trophoblast Cells Proliferation and Invasion Through miR-144/Titin Axis. Yu N; Liang Y; Zhu H; Mo H; Pei H J Cell Biochem; 2017 Aug; 118(8):2208-2218. PubMed ID: 28059474 [TBL] [Abstract][Full Text] [Related]
39. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer. Tantai J; Hu D; Yang Y; Geng J Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability. Liu L; He J; Wei X; Wan G; Lao Y; Xu W; Li Z; Hu H; Hu Z; Luo X; Wu J; Xie W; Zhang Y; Xu N Oncogene; 2017 Oct; 36(42):5874-5884. PubMed ID: 28628113 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]